Currently, patients who have had a kidney transplant must take a cocktail of pills every day for the rest of their lives.

Please provide your email address to receive an email when new articles are posted on . In the United States, the annual rate of growth in incident patients with end-stage kidney disease has slowed.

Chlorthalidone appears as effective as hydrochlorothiazide in slowing progression to chronic kidney disease among patients with hypertension. Kidney function decline occurs no faster when patients ...

In this analysis of patients with myeloperoxidase-ANCA-positive AAV, all urinary complement C3 fragment levels were elevated significantly compared with healthy controls (P <.01 for all).

As concerns rise about the effects of tiny plastic particles on human health, Flinders University researchers have led new research on whether nanoplastics can accumulate or cause damage in ...

Patients with immunoglobin A nephropathy who reached complete remission of proteinuria with sparsentan had greater eGFR ...

Medically reviewed by David Ozeri, MD Complement 3 glomerulopathy (C3G) is a rare kidney disorder—in many cases, the exact ...

A new study offers hope that kidney transplant patients could one day have a monthly treatment instead of multiple pills ...